1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > General Medicine and Specialty Medicine Analysis & Statistics, August 2016 (p3)

General Medicine and Specialty Medicine Analysis & Statistics, August 2016 (p3)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

61-90 of about 3 000 reports

Purchase Reports From Reputable Market Research Publishers

Asia Pacific Sports Medicine Market - Growth, Trends and Forecasts (2015 - 2020)

Asia Pacific Sports Medicine Market - Growth, Trends and Forecasts (2015 - 2020)

  • $ 3 850
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Asia Pacific Sports medicine market is valued at USD 2.94 billion for the year 2015 and is expected to reach USD 4.11 billion by the end of 2020. The market is estimated to grow at a CAGR of 6.96% ...

  • Industries : General Medicine and Specialty Medicine, Healthcare, Sport, Sport, Sport
  • Countries : Asia
South America CT Market - Growth, Trends And Forecasts (2015-2020)

South America CT Market - Growth, Trends And Forecasts (2015-2020)

  • $ 3 850
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Latin America CT Scanners market is poised to reach $XX billion by the end of 2020 growing at a CAGR of XX%.Computed tomography (CT) is an imaging process that customs special x-ray equipment to generate ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : United States
Europe Nuclear Medicine Market – Trends And Forecasts (2015-2020)

Europe Nuclear Medicine Market – Trends And Forecasts (2015-2020)

  • $ 3 850
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Europe Nuclear Medicine Market is expected to reach USD 4,660 million by the end of 2020 growing at a CAGR of around 10% from 2015 to 2020. Nuclear Medicine utilizes the radioisotope for application ...

  • Industries : General Medicine and Specialty Medicine, Diagnostic Imaging
  • Countries : Europe
North America Nuclear Imaging Market - Growth, Trends And Forecast (2015 - 2020)

North America Nuclear Imaging Market - Growth, Trends And Forecast (2015 - 2020)

  • $ 3 850
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The nuclear imaging market is estimated to grow to $15.5 million by 2020 at a CAGR of 12.08%. Nuclear medicine is the use of radioisotopes for the diagnosis of diseases. The two major types of Nuclea ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : North America
Europe Melanoma Diagnostics and Therapeutics Market - Segmented by type of cancer and Geography (2015-2020)

Europe Melanoma Diagnostics and Therapeutics Market - Segmented by type of cancer and Geography (2015-2020)

  • $ 3 850
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Europe melanoma diagnostics and therapeutics market was valued at USD 454 million in 2015 and is expected to reach USD 915 million by 2020. Melanoma is one of the serious types of skin cancer that ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : Europe
Asia-Pacific Melanoma Diagnostics and therapeutic market - segmented by type of cancer and geography (2015-2020)

Asia-Pacific Melanoma Diagnostics and therapeutic market - segmented by type of cancer and geography (2015-2020)

  • $ 3 850
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Asia-Pacific melanoma diagnostics and therapeutics market was valued at USD 532 million in 2015 and is expected to reach USD 1,172 million by 2020. Melanoma is one of the serious types of skin cance ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : Asia
Latin America Melanoma Diagnostics and Therapeutics Market - Segmented by type of cancer and Geography (2015-2020)

Latin America Melanoma Diagnostics and Therapeutics Market - Segmented by type of cancer and Geography (2015-2020)

  • $ 3 850
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Latin America melanoma diagnostics and therapeutics market was valued at USD 106 million in 2015 and is expected to reach USD 234 million by 2020. Melanoma is one of the serious types of skin cance ...

  • Industries : General Medicine and Specialty Medicine
Europe Bariatric Surgery Market - Mordor Intelligence

Europe Bariatric Surgery Market - Mordor Intelligence

  • $ 3 850
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Europe Bariatric Surgery Market has been estimated at USD 514.5 million in 2015 and is projected to reach USD 977.9 million by 2020. Bariatric surgery includes a range of procedures to be performed ...

  • Industries : General Medicine and Specialty Medicine, Medical Device, Healthcare
  • Countries : Europe
Middle East CT Market - Growth, Trends And Forecasts (2015 - 2020)

Middle East CT Market - Growth, Trends And Forecasts (2015 - 2020)

  • $ 3 850
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Middle East & Africa CT Scanners market is poised to reach $XX billion by the end of 2020 growing at a CAGR of XX%.Computed tomography (CT) is an imaging process that customs special x-ray equipment ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : Africa
Europe Telemedicine Market – Growth, Trends And Forecasts (2015-2020)

Europe Telemedicine Market – Growth, Trends And Forecasts (2015-2020)

  • $ 3 850
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Europe Telemedicine Market has been estimated to be USD XX billion in 2015 and it is projected to reach USD XX billion by 2020 at a CAGR of XX% during the forecast period from 2015 to 2020. Telemedicine ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : Europe
World Nuclear Medicine/Radiopharmaceuticals Market - Opportunities and Forecasts, 2014 - 2022

World Nuclear Medicine/Radiopharmaceuticals Market - Opportunities and Forecasts, 2014 - 2022

  • $ 3 840
  • Industry report
  • July 2016
  • by Allied Market Research

Radiopharmaceuticals are pharmaceutical formulations comprising radioactive isotopes that are used in diagnosis and therapeutics. They are simple and small substances that contain a radioactive substance ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : World
World Nuclear Medicine/Radiopharmaceuticals Market - Opportunities and Forecasts, 2014 - 2022

World Nuclear Medicine/Radiopharmaceuticals Market - Opportunities and Forecasts, 2014 - 2022

  • $ 3 840
  • Industry report
  • July 2016
  • by Allied Market Research

Radiopharmaceuticals are pharmaceutical formulations comprising radioactive isotopes that are used in diagnosis and therapeutics. They are simple and small substances that contain a radioactive substance ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : World
US Cardiovascular Devices Pipeline Product Analysis - Stage, Indication and Estimated Approval Date

US Cardiovascular Devices Pipeline Product Analysis - Stage, Indication and Estimated Approval Date

  • $ 3 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Cardiovascular Devices are used to diagnose and treat heart diseases and related health problems. This report provides Pipeline Analysis of the Cardiovascular Devices in the United States region. This ...

  • Industries : Cardiovascular Devices, Medical Device
  • Countries : United States
Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2025

Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2025

  • $ 3 500
  • Industry report
  • July 2016
  • by Kalorama Information

Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2025 examines the leaders in the pharmaceutical industry, including the late-term pipeline of major companies. This report provides ...

  • Industries : Pharmaceutical
  • Countries : United States, World
Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H2 2016

Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Integrin Beta 1 (Fibronectin ...

  • Industries : Therapy, Biopharmaceutical, Pharmaceutical, Drug Discovery and Development
  • Countries : World
High Affinity Nerve Growth Factor Receptor (Neurotrophic Tyrosine Kinase Receptor Type 1 or TRK1 Transforming Tyrosine Kinase Protein or Tropomyosin Related Kinase A or Tyrosine Kinase Receptor or gp140trk or p140 TrkA or NTRK1 or EC 2.7.10.1) - Pipeline

High Affinity Nerve Growth Factor Receptor (Neurotrophic Tyrosine Kinase Receptor Type 1 or TRK1 Transforming Tyrosine Kinase Protein or Tropomyosin Related Kinase A or Tyrosine Kinase Receptor or gp140trk or p140 TrkA or NTRK1 or EC 2.7.10.1) - Pipeline

  • $ 3 500
  • Industry report
  • July 2016
  • by Global Markets Direct

High Affinity Nerve Growth Factor Receptor (Neurotrophic Tyrosine Kinase Receptor Type 1 or TRK1 Transforming Tyrosine Kinase Protein or Tropomyosin Related Kinase A or Tyrosine Kinase Receptor or gp140trk ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States
Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H2 2016

Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H2 2016’, provides in depth analysis on Toll ...

  • Industries : Therapy, Pathology, Biopharmaceutical, Biotechnology, Pharmaceutical
  • Countries : United States, Europe, World
NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H1 2016

NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘NT ...

  • Industries : Cancer, Pathology
  • Countries : United States
RAF Proto-Oncogene Serine/Threonine-Protein Kinase (C-Raf Kinase or Proto-Oncogene c-RAF or Raf-1 or EC 2.7.11.1) - Pipeline Review, H1 2016

RAF Proto-Oncogene Serine/Threonine-Protein Kinase (C-Raf Kinase or Proto-Oncogene c-RAF or Raf-1 or EC 2.7.11.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

RAF Proto-Oncogene Serine/Threonine-Protein Kinase (C-Raf Kinase or Proto-Oncogene c-RAF or Raf-1 or EC 2.7.11.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘RAF Proto-Oncogene Se ...

  • Industries : Therapy, Cancer, Pathology
  • Countries : United States
BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H1 2016

BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H1 2016 ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States
Potassium Voltage Gated Channel Subfamily KQT Member 2 (Neuroblastoma Specific Potassium Channel Subunit Alpha KvLQT2 or Voltage Gated Potassium Channel Subunit Kv7.2 or KCNQ2) - Pipeline Review, H1 2016

Potassium Voltage Gated Channel Subfamily KQT Member 2 (Neuroblastoma Specific Potassium Channel Subunit Alpha KvLQT2 or Voltage Gated Potassium Channel Subunit Kv7.2 or KCNQ2) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Potassium Voltage Gated Channel Subfamily KQT Member 2 (Neuroblastoma Specific Potassium Channel Subunit Alpha KvLQT2 or Voltage Gated Potassium Channel Subunit Kv7.2 or KCNQ2) - Pipeline Review, H1 2016 ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Serine/Threonine-Protein Kinase A-Raf (A-Raf Kinase or Proto-Oncogene A-Raf or Proto-Oncogene Pks or EC 2.7.11.1) - Pipeline Review, H1 2016

Serine/Threonine-Protein Kinase A-Raf (A-Raf Kinase or Proto-Oncogene A-Raf or Proto-Oncogene Pks or EC 2.7.11.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Serine/Threonine-Protein Kinase A-Raf (A-Raf Kinase or Proto-Oncogene A-Raf or Proto-Oncogene Pks or EC 2.7.11.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Serine/Threonine-Protein ...

  • Industries : Therapy, Cancer, Biopharmaceutical, Pathology
  • Countries : United States, World
Interleukin 12 Subunit Beta (Cytotoxic Lymphocyte Maturation Factor 40 kDa Subunit or CLMF p40 or IL12 Subunit p40 NK Cell Stimulatory Factor Chain 2 or IL12B) - Pipeline Review, H1 2016

Interleukin 12 Subunit Beta (Cytotoxic Lymphocyte Maturation Factor 40 kDa Subunit or CLMF p40 or IL12 Subunit p40 NK Cell Stimulatory Factor Chain 2 or IL12B) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Interleukin 12 Subunit Beta (Cytotoxic Lymphocyte Maturation Factor 40 kDa Subunit or CLMF p40 or IL12 Subunit p40 NK Cell Stimulatory Factor Chain 2 or IL12B) - Pipeline Review, H1 2016 Summary Global ...

  • Industries : Pathology, Therapy, Biological Therapy, Biotechnology
  • Countries : United States
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF-2 or bFGF) - Pipeline Review, H1 2016

Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF-2 or bFGF) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF-2 or bFGF) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Fibroblast Growth Facto ...

  • Industries : Therapy, Pathology, Cancer, Pharmaceutical
  • Countries : United States, World
Placental Growth Factor (PIGF or Vascular Endothelial Growth Factor Related Protein) - Pipeline Review, H1 2016

Placental Growth Factor (PIGF or Vascular Endothelial Growth Factor Related Protein) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Placental Growth Factor (PIGF or Vascular Endothelial Growth Factor Related Protein) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Placental Growth Factor (PIGF or Vascular Endothelial ...

  • Industries : Therapy, Biopharmaceutical, Pathology, Pharmaceutical
  • Countries : United States, World
Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H1 2016

Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H1 2016’, provides ...

  • Industries : Pathology, Therapy, Pharmaceutical
  • Countries : World, United States, Europe
Coagulation Factor XI (Plasma Thromboplastin Antecedent or EC 3.4.21.27) - Pipeline Review, H1 2016

Coagulation Factor XI (Plasma Thromboplastin Antecedent or EC 3.4.21.27) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Coagulation Factor XI (Plasma Thromboplastin Antecedent or EC 3.4.21.27) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Coagulation Factor XI (Plasma Thromboplastin Antecedent or EC 3.4.21.27) ...

  • Industries : In Vitro Diagnostics, Pathology, Pharmaceutical
  • Countries : United States
Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H1 2016

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Histone Deacetylase 6 (Protein Phosphatase 1 ...

  • Industries : Pathology, Cancer, Therapy, Pharmaceutical
  • Countries : United States
Metabotropic Glutamate Receptor 5 (mGluR5 or GRM5 or GPRC1E or MGLUR5) - Pipeline Review, H1 2016

Metabotropic Glutamate Receptor 5 (mGluR5 or GRM5 or GPRC1E or MGLUR5) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

Metabotropic Glutamate Receptor 5 (mGluR5 or GRM5 or GPRC1E or MGLUR5) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Metabotropic Glutamate Receptor 5 (mGluR5 or GRM5 or GPRC1E or MGLUR5) ...

  • Industries : Mental Health, Pathology, Therapy
  • Countries : World, United States
Eukaryotic Translation Initiation Factor 4E (eIF-4E) - Pipeline Review, H1 2016

Eukaryotic Translation Initiation Factor 4E (eIF-4E) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • May 2016
  • by Global Markets Direct

Eukaryotic Translation Initiation Factor 4E (eIF-4E) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Eukaryotic Translation Initiation Factor 4E (eIF-4E) - Pipeline Review, H1 2016’, ...

  • Industries : Therapy, Cancer, Pathology, Drug Discovery and Development
  • Countries : United States, World

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.